ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983

Supporters And A Critic Of Burzynski Comment

October 30, 1998

Small Businesses Receive $18 Million From NCI Through SBIR Program

July 31, 1992

In Brief: Broder to Discuss Centers Plan Between Meeting; Symposium Depicted To William Scott

May 11, 1990

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008

Congressman Requests GAO Inquiry into FDA Foreign Inspections

April 19, 1996